𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum soluble interleukin-2 receptor levels in patients with malignant lymphoma of bone

✍ Scribed by Tsutomu Akahane; Tominaga Shimizu; Ken’ichi Isobe; Yasuo Yoshimura; Hiroyuki Kato

Publisher
Springer Japan
Year
2009
Tongue
English
Weight
323 KB
Volume
14
Category
Article
ISSN
0949-2658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of soluble interleukin-2 re
Serum levels of soluble interleukin-2 receptor
✍ Yosef Uziel; Bernice R. Krafchik; Brian Feldman; Earl D. Silverman; Laurence A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views
Serum-soluble interleukin-2 receptor con
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer
✍ Saburo Murakami; Akira Safomi; Kiyoshi Lshida; Hideaki Murai; Moriyuki Mafsuki; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 2 views

Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo

Serum-soluble interleukin-2 receptors in
Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies
✍ Pavlidis, Nicholas A. ;Manoussakis, Menelaus N. ;Germanidis, George S. ;Moutsopo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract The levels of soluble interleukin‐2 receptors (sIL‐2R) were determined in the serum of 53 patients with B‐cell lymphoproliferative malignancies, including 31 patients with non‐Hodgkin lymphomas (NHL), 16 with chronic lymphocytic leukemia (CLL), and 6 with multiple myeloma. In addition,